Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10033506HBVENSG00000135333.15protein_codingEPHA7YesYes2045Q15375
TVIS30083157HIVENSG00000135333.15protein_codingEPHA7YesYes2045Q15375
TVIS20002992HPVENSG00000135333.15protein_codingEPHA7YesYes2045Q15375
TVIS20004402HPVENSG00000135333.15protein_codingEPHA7YesYes2045Q15375
TVIS20061231HPVENSG00000135333.15protein_codingEPHA7YesYes2045Q15375
TVIS20060491HPVENSG00000135333.15protein_codingEPHA7YesYes2045Q15375
TVIS20041244HPVENSG00000135333.15protein_codingEPHA7YesYes2045Q15375
TVIS20027952HPVENSG00000135333.15protein_codingEPHA7YesYes2045Q15375
TVIS20070091HPVENSG00000135333.15protein_codingEPHA7YesYes2045Q15375
TVIS20027951HPVENSG00000135333.15protein_codingEPHA7YesYes2045Q15375
TCGA Plot Options
Drug Information
GeneEPHA7
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0004140
UniProt IDQ15375
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830